Petros Pharmaceuticals Statistics Share Statistics Petros Pharmaceuticals has 31.16M
shares outstanding. The number of shares has increased by 0.06%
in one year.
Shares Outstanding 31.16M Shares Change (YoY) 0.06% Shares Change (QoQ) -0.01% Owned by Institutions (%) 3.35% Shares Floating 29.95M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 238.06K, so 0.76% of the outstanding
shares have been sold short.
Short Interest 238.06K Short % of Shares Out 0.76% Short % of Float 0.77% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -5.52 and the forward
PE ratio is null.
Petros Pharmaceuticals's PEG ratio is
0.06.
PE Ratio -5.52 Forward PE n/a PS Ratio 15.46 Forward PS n/a PB Ratio -10.59 P/FCF Ratio -30.09 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Petros Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.4,
with a Debt / Equity ratio of -0.99.
Current Ratio 0.4 Quick Ratio 0.33 Debt / Equity -0.99 Debt / EBITDA -0.68 Debt / FCF -2.81 Interest Coverage -31.52
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $284K Profits Per Employee $-795.49K Employee Count 18 Asset Turnover 0.48 Inventory Turnover 0.9
Taxes Income Tax 26.78B Effective Tax Rate -187046.81%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 1.76, so Petros Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.76 52-Week Price Change n/a 50-Day Moving Average 0.72 200-Day Moving Average 5.57 Relative Strength Index (RSI) 27.07 Average Volume (20 Days) n/a
Income Statement In the last 12 months, Petros Pharmaceuticals had revenue of 5.11M
and earned -14.32M
in profits. Earnings per share was -0.02.
Revenue 5.11M Gross Profit 3.9M Operating Income -17.68M Net Income -14.32M EBITDA -10.81M EBIT -13.76M Earnings Per Share (EPS) -0.02
Full Income Statement Balance Sheet The company has 3.71M in cash and 7.39M in
debt, giving a net cash position of -3.68M.
Cash & Cash Equivalents 3.71M Total Debt 7.39M Net Cash -3.68M Retained Earnings -113.21M Total Assets 17.61M Working Capital -12.67M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -2.6M
and capital expenditures -24.59K, giving a free cash flow of -2.63M.
Operating Cash Flow -2.6M Capital Expenditures -24.59K Free Cash Flow -2.63M FCF Per Share -0.33
Full Cash Flow Statement Margins Gross margin is 76.28%, with operating and profit margins of -345.84% and -280.1%.
Gross Margin 76.28% Operating Margin -345.84% Pretax Margin -280.1% Profit Margin -280.1% EBITDA Margin -211.54% EBIT Margin -345.84% FCF Margin -51.4%
Dividends & Yields PTPI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for PTPI.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 1, 2025. It was a
backward
split with a ratio of 1:25.
Last Split Date May 1, 2025 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -12.28 Piotroski F-Score 4
